Outcome of the Board Meeting held on Saturday, November 15, 2025 considered and approved the conversion of 7,35,000 warrants into 7,35,000 equity shares of face value of Rs. 10/- (Rupees Ten Only)
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Shelter Pharma Ltd, at its meeting on November 15, 2025, approved the conversion of 7,35,000 convertible warrants into an equal number of equity shares of Rs. 10 face value each. These warrants were originally allotted on a preferential basis at Rs. 42.25 per warrant, with 25% paid upfront at allotment. The warrant holders have now paid the remaining 75% (Rs. 31.6875 per share), bringing in Rs. 2.33 crore. All 7,35,000 warrants belong to three non-promoter allottees, whose entire warrant holdings are now fully converted with none outstanding. As a result, the company's paid-up equity share capital has risen from Rs. 14.86 crore (1.48 crore shares) to Rs. 15.60 crore (1.56 crore shares).
Minor dilution of about 4.9% in existing shareholders' stake due to the new shares issued at a premium over face value. The cash inflow of Rs. 2.33 crore strengthens the company's capital base, though it is a small amount relative to overall share capital.